Auris Medical develops novel pharmaceutical therapies to PREvent and treat severe inner ear disorders.
Auris Medical has raised €46M across 2 funding rounds from 2 investors, most recently a Series C round in Apr 2013. Based in Basel, Switzerland; founded 2003; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2013-04-01 | Series C | €40M | Sofinnova Partners | View deal → |
| 2008-02-01 | Series B | €6.8M | IDInvest Partners | View deal → |